Is your Therapeutic Protein Characterization Pipeline Ready for the Future?
Mass Spectrometry is an increasingly important tool to support the development of therapeutic proteins. This means laboratories need to be adequately prepared for enhanced regulatory demands and increased throughput requirements.
Download these eBooks to learn how BioPharma Compass helps you rise to this challenge by:
- Providing tools for CFR21 compliance, including management of the raw data files and centralized management of acquisition and processing procedures
- Advanced support for high resolution subunits, reduced and intact mAbs screening
- MS/MS based peptide characterization results can be transformed in MS based multi-attribute monitoring method
- Support for complementary ESI and MALDI data
Download these eBooks to learn how BioPharma Compass helps you rise to this challenge by:
- Providing tools for CFR21 compliance, including management of the raw data files and centralized management of acquisition and processing procedures
- Advanced support for high resolution subunits, reduced and intact mAbs screening
- MS/MS based peptide characterization results can be transformed in MS based multi-attribute monitoring method
- Support for complementary ESI and MALDI data
